Checkerspot introduces a revolutionary infant nutrition breakthrough with its fat innovation, oleic-palmitic-oleic (OPO) or sn-2 palmitate, derived from microalgae fermentation. This alternative to conventional oils promises enhanced nutrient profiles for infant formulas. While not perfectly mimicking human milk composition, it significantly improves fat structure, potentially aiding digestion, nutrient absorption, and long-term health benefits. Current infant formulas lack sufficient sn-2 palmitate, falling below the levels in human milk. Checkerspot’s microalgal oil production platform yields a unique human milk fat analogue, boasting approximately 73% of total palmitic acid. Despite concerns over microalgae fermentation complexity and cost, Checkerspot highlights advancements and sustainability measures, including waste repurposing. With an emphasis on environmental and regulatory diligence, the company seeks GRAS status in the US and novel food approval in the EU. Checkerspot’s commitment to infant health and environmental responsibility marks a significant advancement in infant nutrition science.
Source: https://www.frontiersin.org/articles/10.3389/fnut.2024.1341527/full
